Lisa Dalton

Insider Reports History

Location
Philadelphia, PA
Signature
/s/ J. Christopher Naftzger, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lisa Dalton:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nabriva Therapeutics plc Director Ordinary Shares 9,100 $13,650 $1.50 31 Jul 2022 Direct

Insider Reports Filed by Lisa Dalton

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465922085788-dalton-lisa-2022-07-31 Nabriva Therapeutics plc 31 Jul 2022 1 -$1,504 4 Director 03 Aug 2022, 21:46
/report/000110465921098422-dalton-lisa-2021-07-28 Nabriva Therapeutics plc 28 Jul 2021 2 $0 4 Director 30 Jul 2021, 20:17
/report/000110465921077207-dalton-lisa-2021-06-02 Nabriva Therapeutics plc 02 Jun 2021 1 $0 4 Director 04 Jun 2021, 17:51
/report/000110465921077203-dalton-lisa-2021-06-02 Nabriva Therapeutics plc 02 Jun 2021 0 $0 3 Director 04 Jun 2021, 17:48